Aytu BioPharma (AYTU) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free AYTU Stock Alerts $3.32 -0.03 (-0.90%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Aytu BioPharma Short Interest DataCurrent Short Volume383,000 sharesPrevious Short Volume402,500 sharesChange Vs. Previous Month-4.84%Dollar Volume Sold Short$1.08 millionShort Interest Ratio / Days to Cover18.5Last Record DateApril 30, 2024Outstanding Shares5,570,000 sharesFloat Size5,360,000 sharesShort Percent of Float7.15%Today's Trading Volume22,424 sharesAverage Trading Volume18,635 sharesToday's Volume Vs. Average120% Short Selling Aytu BioPharma ? Sign up to receive the latest short interest report for Aytu BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAYTU Short Interest Over TimeAYTU Days to Cover Over TimeAYTU Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Aytu BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024383,000 shares $1.08 million -4.8%7.2%18.5 $2.81 4/15/2024402,500 shares $1.07 million +11.5%7.5%19.8 $2.67 3/31/2024360,900 shares $1.10 million -0.2%6.7%18 $3.04 3/15/2024361,600 shares $1.04 million +3.5%6.8%16.9 $2.87 2/29/2024349,500 shares $1.01 million +4.4%6.5%14.8 $2.89 2/15/2024334,900 shares $1.04 million +6.3%6.3%14.6 $3.12 Get the Latest News and Ratings for AYTU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024315,100 shares $860,223.00 -9.6%5.9%11 $2.73 1/15/2024348,500 shares $892,160.00 -7.4%6.5%9.1 $2.56 12/31/2023376,300 shares $1.07 million -8.2%7.0%7.9 $2.84 12/15/2023409,800 shares $1.20 million -11.7%7.7%2.5 $2.93 11/30/2023464,000 shares $1.06 million -23.1%8.7%2.8 $2.29 11/15/2023603,000 shares $1.38 million -4.7%11.3%3.7 $2.29 10/31/2023632,800 shares $1.73 million -14.9%12.1%4 $2.73 10/15/2023743,200 shares $2.22 million +112.6%14.2%4.8 $2.99 9/30/2023349,600 shares $943,920.00 +5.8%9.8%2.4 $2.70 9/15/2023330,300 shares $535,086.00 -6.4%9.3%11.2 $1.62 8/31/2023352,800 shares $599,760.00 +12.0%9.9%8.9 $1.70 8/15/2023314,900 shares $588,863.00 -1.7%8.8%6.8 $1.87 7/31/2023320,200 shares $579,562.00 -6.2%8.9%5.6 $1.81 7/15/2023341,500 shares $638,605.00 -8.8%9.5%4.1 $1.87 6/30/2023374,600 shares $599,360.00 -39.3%10.5%4.4 $1.60 6/15/2023616,700 shares $1.14 million +3.3%17.2%7.4 $1.85 5/31/2023596,800 shares $996,656.00 -0.1%16.6%7.4 $1.67 5/15/2023597,300 shares $1.07 million +23.6%16.6%7.2 $1.79 4/30/2023483,200 shares $1.14 million -9.6%14.3%6.2 $2.35 4/15/2023534,300 shares $1.36 million +4.1%15.8%9.8 $2.55 3/31/2023513,200 shares $1.15 million +3.1%15.2%7.9 $2.24 3/15/2023497,600 shares $1.17 million +0.8%14.7%6.2 $2.35 2/28/2023493,900 shares $1.31 million +12.3%15.3%6.4 $2.66 2/15/2023440,000 shares $1.31 million +8.7%13.7%5.7 $2.98 1/31/2023404,700 shares $1.34 million +16.9%12.5%5.3 $3.30 1/15/2023346,300 shares $1.20 million +99.3%10.8%4.8 $3.47 12/30/2022173,800 shares $32,848.20 -93.9%N/A2.8 $0.19 12/15/20222,830,000 shares $602,507.00 -6.3%N/A2.6 $0.21 11/30/20223,020,000 shares $619,402.00 +24.8%N/A3 $0.21 11/15/20222,420,000 shares $473,110.00 +36.0%N/A2.3 $0.20 10/31/20221,780,000 shares $291,920.00 No ChangeN/A1.3 $0.16 10/15/20221,780,000 shares $295,658.00 +17.9%N/A1.3 $0.17 9/30/20221,510,000 shares $279,350.00 +42.5%N/A1.1 $0.19 9/15/20221,060,000 shares $231,080.00 -8.6%N/A0.8 $0.22Trump’s Former Wingman Bets Big on AI (Ad)One of his AI company’s earliest investors was the CIA’s venture capital arm called In-Q-Tel … named after Q, the fictional character who makes gadgets for James Bond. Soon, an alphabet soup of 30 government agencies would entrust the company with their most sensitive information.Get the full story here. AYTU Short Interest - Frequently Asked Questions What is Aytu BioPharma's current short interest? Short interest is the volume of Aytu BioPharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 383,000 shares of AYTU short. 7.15% of Aytu BioPharma's shares are currently sold short. Learn More on Aytu BioPharma's current short interest. What is a good short interest ratio for Aytu BioPharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AYTU shares currently have a short interest ratio of 18.0. Learn More on Aytu BioPharma's short interest ratio. Which institutional investors are shorting Aytu BioPharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aytu BioPharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aytu BioPharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.15% of Aytu BioPharma's floating shares are currently sold short. Is Aytu BioPharma's short interest increasing or decreasing? Aytu BioPharma saw a decline in short interest in April. As of April 30th, there was short interest totaling 383,000 shares, a decline of 4.8% from the previous total of 402,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aytu BioPharma's float size? Aytu BioPharma currently has issued a total of 5,570,000 shares. Some of Aytu BioPharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aytu BioPharma currently has a public float of 5,360,000 shares. How does Aytu BioPharma's short interest compare to its competitors? 7.15% of Aytu BioPharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aytu BioPharma: Galecto, Inc. (0.42%), Sol-Gel Technologies Ltd. (0.04%), Indaptus Therapeutics, Inc. (0.44%), VBI Vaccines Inc. (1.38%), Cocrystal Pharma, Inc. (0.11%), GlycoMimetics, Inc. (9.45%), Minerva Neurosciences, Inc. (0.47%), Talphera, Inc. (0.90%), KALA BIO, Inc. (0.36%), NeuroBo Pharmaceuticals, Inc. (2.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Aytu BioPharma stock? Short selling AYTU is an investing strategy that aims to generate trading profit from Aytu BioPharma as its price is falling. AYTU shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aytu BioPharma? A short squeeze for Aytu BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AYTU, which in turn drives the price of the stock up even further. How often is Aytu BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AYTU, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: GLTO Short Interest Data SLGL Short Interest Data INDP Short Interest Data VBIV Short Interest Data COCP Short Interest Data GLYC Short Interest Data NERV Short Interest Data TLPH Short Interest Data KALA Short Interest Data NRBO Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AYTU) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersBill Clinton Backing Biden Replacement???The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable Prosperity